PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cancer and rare disease

Ultragenyx Signs a License Agreement with Mereo for Setrusumab in Osteogenesis Imperfecta

Ultragenyx Signs a License Agreement with Mereo for Setrusumab in Osteogenesis Imperfecta

December 21, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us